FluroTech Wins Best of Show Award After Impressive Live Testing
February 28th, 2019
Exclusive, News, Top News
Vancouver’s LIFT Expo is Canada’s largest cannabis trade show where established incumbents and new startups unveil their hottest new products. From Blade Filters’ green carbon air filters to Nitrotin’s canned cannabis, there is no shortage of innovative products targeting the nascent cannabis industry. Some of these companies will emerge to become new leaders in important subsets of the cannabis industry.
FluroTech Ltd. (TSX-V: TEST) (OTCQB: FLURF) debuted its CompleTest™ to the public for the first time at the 2019 LIFT Expo. Master growers and quality assurance personnel were impressed by live demonstrations showing the technology’s simplicity, speed, accuracy, and consistency of results, which could enable them to bring a lot of analytical tasks in-house that were previously outsourced to third-party laboratories.
Best of Show for New Technology
High! Canada Magazine awarded CompleTest™ with their Best of Show for New Technology award following the 2019 LIFT Expo. The award underscores the unique value proposition that the company’s technology offers to licensed producers and other cultivators that want to access precise data to fine-tune their growing conditions to optimize quality and yield. The results can also confirm third-party test results to avoid any misunderstandings.
“The award was unexpected,” said FluroTech VP of Business Development Gary Jones in a recent press release announcing the award. “The Vancouver LIFT Expo was the first time that FluroTech unveiled the CompleTest™ to the public. Master growers recognized that they could affordably and accurately use the in-house testing device to select mother plants for breeding or to optimize their potency yield for a given strain.”
Co-founder and CEO Danny Dalla Longa, an experienced businessman, CTO Dr. Prenner, a specialist in fluorescence spectroscopy, and COO Rex Kary, an experienced marketing and finance executive, plan to enter the market with unique testing capabilities before expanding into biomarking to revolutionize the cannabis supply chain. These long-term aspirations could make it one of the industry’s most promising new technologies.
COO Rex Kary commented saying “CompleTest™ is a tool all growers can use to significantly increase yield and profitability by having accurate in-house test results in 30 minutes”.
Providing a Better Alternative
The CompleTest™ provides a fast, affordable, cost-effective and accurate test for tetrahydrocannabinol (THCa), cannabidiol (CBDa) and heavy metals with pesticides and aflatoxin tests expected Q2. The testing process involves mixing a small sample of ground buds with a reagent solution and placing it into the CompleTest™ for about 60 seconds. When the test is complete, the results are sent immediately to a tablet for review.
By comparison, most existing testing solutions involve $500,000 ICP-MS equipment for heavy metal tests or $100,000 high performance liquid chromatography equipment to test cannabinoids that require experienced personnel to operate. These tests routinely take from a couple hours to several weeks to turnaround, which can be a long time when cultivators depend on the results to guide their grow operations or determine if product is safe.
Many third-party laboratories also produce different results since use machines with varying levels of calibration and personnel with varying levels of experience. FluroTech’s CompleTest™ produces extremely consistent results that are within one percent of acceptable variance. Cultivators can rely on the device to produce consistent and reliable results without the possibility of human interpretation errors or miscalibration causing any issues.
Unique Opportunity for Investors
The market for cannabis testing is rapidly growing thanks to expansive regulations and intensifying competition among cultivators. In a recent study, growers using CompleTest™ used the device to identify lighting solutions that increased potency by 50 percent, which is significant given that each one percent increase in potency translates to an 8.3 percent increase in the value of cannabis extracts!
FluroTech Ltd.’s (TSX-V: TEST) (OTCQB: FLURF) CompleTest™ is not only a technological breakthrough delivering significant benefits to cultivators, it offers investors a compelling razor-razorblade business model. In addition to the $18,000 unit sale and one-off $6000 scope sales, the company generates an estimated $20,000 per year in revenue per device from scopes and test kits that are required to run each test, creating predictable recurring revenue for investors.
For more information, visit the company’s website
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/
Follow Us on Social Media
About CFN Media
CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.
CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.